MARKET NEWS

English
Specials
Moneycontrol Be a PRO
you are here:
Success
Alert
Please select a Day.
Info
Open Trading Account

Aurobindo Pharma Ltd.

Sector: Pharmaceuticals
Add to
1,030.90
-17.05 (-1.63%)

As on 11 May, 2021 | 03:55

Trade
Day Range
1018.90
1063.90
L H
52 Week Range
647.25
1063.90
L H
Volume
2,669,450
*
i

* BSE Market Depth (11 May 2021)

BUY SELL
QTY PRICE PRICE QTY
60 1028.00 1029.95 151
20 1026.30 1034.10 108
56 1026.00 1034.20 5
7 1025.00 1035.00 6
8 1024.00 1036.00 55
0 Total Total 0
Bid / Ask
0.00 / 0.00
Advance Chart
1,029.95
-17.65 (-1.68%)

As on 11 May, 2021 | 04:00

Day Range
1019.75
1063.75
L H
52 Week Range
525.05
1063.75
L H
Volume
131,171
*
i

* BSE Market Depth (11 May 2021)

BUY SELL
QTY PRICE PRICE QTY
60 1028.00 1029.95 151
20 1026.30 1034.10 108
56 1026.00 1034.20 5
7 1025.00 1035.00 6
8 1024.00 1036.00 55
0 Total Total 0
Bid / Ask
0.00 / 0.00
Advance Chart
--
-- (--%)

As on --

Day Range
--
--
L H
Open Interest Analysis
Long Unwinding

(OI , PRICE )

See Historical Trend

Volume
--
Advance Chart
--
-- (--%)

As on --

Day Range
--
--
L H
Moneyness
--
Volume
--
Advance Chart
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
MC Essentials
88% Pass
MC Technicals
 Trend
i
This represents current trend.Click here for disclaimer.
MC Insights

Strong Performer: Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. Currently valued at Good to expensive valuation

Financials
    Ownerships
      Industry Comparison
        Others
          Powered by Powered by Trendlyne
          Open1,041.95
          Previous Close1,047.95
          UC Limit1,152.70
          LC Limit943.20
          Volume2,669,450.00
          VWAP1,038.18
          Mkt Cap (Rs. Cr.)60,404
          20D Avg Volume3,457,324
          20D Avg Delivery878,597
          Beta0.570.47
          Face Value1.00
          TTM EPS91.87
          TTM PE11.22
          Sector PE42.47
          Book Value Per Share286.90
          P/B3.60
          Dividend Yield0.29
          P/C9.51

          Advance Chart

          Click here to expand

          *Refresh in 20 seconds.

          MC Insights

          Strong Performer: Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. Currently valued at Good to expensive valuation

          Price
          • Bullish Momentum - Above Short, Medium and Long Term Moving Averages
          • 57.49% away from 52 week low
          • 3.1% away from 52 week high
          • Outperformer - Aurobindo Pharma up by 9.24% v/s NIFTY 50 up by 0.11% in last 1 month
          • F&O data suggests Long Unwinding today
          • Stock saw 11 number of Large Deals today.Tap to see details.
          Financials
          Piotroski Score
          i
          Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Higher the score, better the financials of the company.
          9

          indicates Strong Financials

          3 year CAGR growth
          Revenue 15.7%
          NetProfit 7.1%
          OperatingProfit 12.3%
          Industry Comparison
          • TTM PE Ratio - Below industry Median
          • Market Cap - High in industry
          • Price to Book Ratio - Above industry Median
          • TTM PEG Ratio - Below industry Median
          Shareholding Pattern
          • Promoters pledged 13.54% of shares in last quarter. Total pledge stands at 22.81% of promoter holdings
          • Promoters holding remains unchanged at 51.94% in Mar 2021 qtr
          • Mutual Funds have decreased holdings from 9.94% to 8.84% in Mar 2021 qtr
          • Number of MF schemes increased from 35 to 36 in Mar 2021 qtr.
          • FII/FPI have decreased holdings from 24.99% to 24.37% in Mar 2021 qtr
          • Number of FII/FPI investors decreased from 714 to 709 in Mar 2021 qtr
          • Institutional Investors have increased holdings from 37.6% to 37.61% in Mar 2021 qtr.
          Powered by Powered by Trendlyne

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

            R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis

          News

          Deregulation of vaccine rollout: What it means for pharma players

          Deregulation of vaccine rollout: What it means for pharma players

          Apr 20 2021 10:04 AM

          ₹ Earning + See More

          Forum

          Community Sentiments

          • 78% BUY
          • 19% SELL
          • 3% HOLD
          78%
          of moneycontrol users recommend buying Aurobindo Pharm

          What's your call on Aurobindo Pharm today?

          Read 15 investor views

          BUY SELL HOLD
          POST

          Broker Research

          30 Mar, 2021

          Sharekhan

          Reco Price 870.15 Target Price 1100
          11 Feb, 2021

          Sharekhan

          Reco Price 935.10 Target Price 1100
          11 Feb, 2021

          ICICIdirect.com

          Reco Price 935.10 Target Price 1165
          17 Dec, 2020

          Sharekhan

          Reco Price 871.90 Target Price 1024
          12 Nov, 2020

          Sharekhan

          Reco Price 838.95 Target Price 1024
          12 Nov, 2020

          Motilal Oswal

          Reco Price 838.95 Target Price 980
          Show More
          Thomson Reuters Report

          Deals

          08 Apr, 2021

          THE MTBJ LTD. AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ400045849

          Qty 131889 Price 905.6 % Traded 0.02
          08 Apr, 2021

          THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MUTB400045794

          Qty 131889 Price 905.6 % Traded 0.02
          07 Apr, 2021

          JHUNJHUNWALA RAKESH

          Qty 1625000 Price 905.65 % Traded 0.28
          07 Apr, 2021

          RARE ENTERPRISES

          Qty 1625000 Price 905.65 % Traded 0.28
          25 Mar, 2019

          POWERSHARES INDIA PORTFOLIO

          Qty 181220 Price 768.3 % Traded 0.03
          25 Mar, 2019

          POWERSHARES MAURITIUS (PINSPV) (679038)

          Qty 181220 Price 768.3 % Traded 0.03
          28 Mar, 2017

          HEMA GOVINDARAJAN

          Qty 200000 Price 682 % Traded 0.03
          28 Mar, 2017

          GOVINDARAJAN NARAYANAN

          Qty 200000 Price 682 % Traded 0.03

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          + Show More
          07 Oct, 2016

          SUNEELA RANI PENAKA

          Qty 8660510 Price 849.3 % Traded 1.48
          19 Sep, 2014

          THE VANGUARD GROUP INC A/C VANGUARD EMERG. MKTS STOCK INDE

          Qty 2360231 Price 875.94 % Traded 0.40
          30 May, 2014

          ABU DHABI INVESTMENT AUTHORUTY - GULAB

          Qty 1475687 Price 670.51 % Traded 0.25
          30 May, 2014

          M/S MORGAN STANLEY ASIA SINGAPORE PTE

          Qty 1732500 Price 669.92 % Traded 0.30
          29 Aug, 2013

          MACQUARIE BANK LIMITED

          Qty 1940000 Price 180.97 % Traded 0.33
          24 Feb, 2011

          RELIANCE CAPITAL TRUSTEE CO. LTD A/C REGULAR SAVING FUND-REL

          Qty 1500000 Price 172.99 % Traded 0.26
          24 Feb, 2011

          HSBC GLOBAL INVESTMENT FUND A/C INDIAN EQUITY FUND

          Qty 2353228 Price 173.03 % Traded 0.40
          26 Aug, 2010

          DEUTSCHE SECURITIES MAURITIUS LTD.

          Qty 375750 Price 1037.53 % Traded 0.06

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          + Show More
          Powered by Powered by Trendlyne

          Insider Transaction Summary

          Apr, 07, 2021

          Kambam Kirthi Reddy

          Promoter Group
          Qty 350000 Price 881.3 % Traded 0.06 Post Tnx Hold. 3.49%
          Apr, 06, 2021

          Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding)

          Promoter Group
          Qty 3600000 Price 882.2 % Traded 0.61 Post Tnx Hold. 2.85%
          Mar, 31, 2021

          RPR Sons Advisors Pvt.Ltd., Mrs.P.Suneela Rani (jointly holding)

          Promoter Group
          Qty 2600000 Price 850.05 % Traded 0.44 Post Tnx Hold. 33.51%
          Mar, 31, 2021

          RPR Sons Advisors Pvt.Ltd., Mrs.P.Suneela Rani (jointly holding)

          Promoter Group
          Qty 1300000 Price 870.4 % Traded 0.22 Post Tnx Hold. 33.51%
          Mar, 31, 2021

          RPR Sons Advisors Pvt.Ltd., Mrs.P.Suneela Rani (jointly holding)

          Promoter Group
          Qty 6600000 Price 881.3 % Traded 1.13 Post Tnx Hold. 33.51%
          Mar, 29, 2021

          RPR Sons Advisors Pvt.Ltd., Mrs.P.Suneela Rani (jointly holding)

          Promoter Group
          Qty 10515862 Price 850.05 % Traded 1.79 Post Tnx Hold. 33.51%

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          Show All Transactions
          Jan, 27, 2021

          HDFC Mutual Fund

          Other
          Qty 11774855 Price 0 % Traded 2.01 Post Tnx Hold. 5.11%
          Jan, 02, 2021

          K Rajewari

          Promoter
          Qty 150000 Price 0 % Traded 0.03 Post Tnx Hold. 0.31%
          Nov, 25, 2020

          Kambam Kirthi Reddy

          Promoter
          Qty 300000 Price 0 % Traded 0.05 Post Tnx Hold. 3.49%
          Nov, 19, 2020

          Kambam Kirthi Reddy (Revised)

          Promoter
          Qty 300000 Price 0 % Traded 0.05 Post Tnx Hold. 3.49%
          Mar, 25, 2020

          Trident Chemphar Limited

          Promoter
          Qty 225000 Price 0 % Traded 0.04 Post Tnx Hold. 0.13%
          Mar, 23, 2020

          Mrs. Kambam Kirthi Reddy

          Promoter
          Qty 50000 Price 0 % Traded 0.01 Post Tnx Hold. 3.54%

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Show All Transactions

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend
          Insights
          Institutional Holder Analysis Total Number Change Total Holding (%) Change
          MF Schemes (Mar 2021) 36 1 8.84 -1.1
          FII/FPI (Mar 2021) 649 -5 24.37 -0.62

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE 1 Yr Perform Net Profit Net Sales Debt to Equity
          Aurobindo Pharm 1030.90 -1.63 60404.41 11.22 3.59 16.84 55.14 2,844 23,098 0.32
          Sun Pharma 708.10 1.42 169896.91 66.30 3.46 8.31 52.66 4,186 32,837 0.17
          Divis Labs 4073.60 -1.59 108141.28 57.81 14.79 18.83 75.07 1,376 5,394 0.00
          Dr Reddys Labs 5295.95 -0.59 88072.30 40.49 5.65 12.98 37.13 1,969 17,517 0.11
          Cipla 890.90 -1.04 71847.81 32.12 4.49 9.81 52.02 1,546 17,131 0.18
          + See More

          About the Company

          Aurobindo Pharma Ltd is engaged in manufacturing semi synthetic penicillin (SSPs).The company has a product presence in key therapeutic segments like SSPs, cephalosporins, antivirals, CNS, cardio-vascular, gastroenterology, etc. They are the market leader in semi-synthetic penicillin drugs.THe company`s product range includes Formulation- In this segment they manufacture formulation for cardio vascular, central nervous system, gastroenterologicals, anti-retrovirals and anti-infectives. They have developed formulations namely Trandolapril, Captopril, Benazepril Hydrochloride, etc.;Active Pharmaceutical Ingredients (API) & Organic Intermediates namely Desmethyl Azithromycin, Methanamine, Benzimidazole, ECPPA and many more.
          {"success":1,"data":{"address":{"address1":"Plot No.2,","address2":"Maitri Vihar,,Ameerpet,","city":"Hyderabad","state":"Telangana","pincode":"500038","telephone1":"040-23736370","telephone2":"","fax1":"040-23743740","fax2":"","email":"info@aurobindo.com","web":"http:\/\/www.aurobindo.com"},"management":[{"name":"K Ragunathan","designation":"Non Executive Chairman"},{"name":"K Nithyananda Reddy","designation":"Vice Chairman & Whole Time Dir"},{"name":"N Govindarajan","designation":"Managing Director"},{"name":"M Sivakumaran","designation":"Whole Time Director"},{"name":"M Madan Mohan Reddy","designation":"Whole Time Director"}],"registrars":{"name":"Karvy Computershare Private Ltd.","address1":"Karvy Selenium Tower B","address2":"Plot no. 31-32, Gachibowli","address3":"Financial District","address4":"Nanakramguda","telephone":"040-23001153","fax":"","email":"","internet":"","city":"Hyderabad","state":"Telangana","pincode":"500032"},"listing":[{"name":"BSE 100","value":"Yes"},{"name":"BSE 200","value":"Yes"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"}],"details":{"bseId":"524804","nseId":"AUROPHARMA","series":"EQ","isinid":"INE406A01037"}}}

          • Registered Office

          • Registrars

            • Address

              Karvy Selenium Tower B,Plot no. 31-32, Gachibowli

            • City

              Hyderabad 500032

            • State

              Telangana

            • Tel. No.

              040-23001153

            • Fax No.

            • Email

            • Internet

          • Management

            • K Ragunathan

              Non Executive Chairman

            • K Nithyananda Reddy

              Vice Chairman & Whole Time Dir

            • N Govindarajan

              Managing Director

            • M Sivakumaran

              Whole Time Director

            • M Madan Mohan Reddy

              Whole Time Director

            + See More

          • Included In

            • BSE 100

              Yes

            • BSE 200

              Yes

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              Yes

          • Details

            • BSE:

              524804

            • NSE:

              AUROPHARMA

            • Series

              EQ

            • ISIN

              INE406A01037

          Go to Top

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>

          Sections
          Desktop Version »
          Follow us on
          Facebook Twitter Instagram Teglegram Jio News
          Available On
          Download from Google Play Download from App Stoer Download from Windows Phone
          Disclaimer | Terms & Conditions | Privacy Policy | Cookie Policy | FAQs | Sitemap | Contact Us | Advertise with Us
          Network 18 Sites: News18 | Firstpost | CNBC TV18 | In.com | Cricketnext | Overdrive | Topper Learning

          Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.